Hodgkin’s lymphoma following treatment with etanercept in ankylosing spondylitis

被引：0
|
作者：
Kenan Aksu
Ayhan Donmez
Yesim Ertan
Gokhan Keser
Vedat Inal
Gonca Oder
Murat Tombuloglu
Yasemin Kabasakal
Eker Doganavsargil
机构：
[1] Ege University School of Medicine Hospital,Internal Medicine
[2] Ege University School of Medicine Hospital,Rheumatology Division
[3] Ege University School of Medicine Hospital,Internal Medicine
来源：
Rheumatology International | 2007年 / 28卷
关键词：
Hodgkin’s lymphoma; Etanercept; Ankylosing spondylitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
It has been well known that anti-TNF drugs might increase lymphoma risk in rheumatoid arthritis (RA), where the rate of lymphoma has already been increased. However, unlike RA, an increased rate of lymphoma has not been reported in ankylosing spondylitis (AS). Hereby, we present a case with AS developing Hodgkin’s lymphoma (HL) following 6 months of etanercept treatment. Pathological analysis revealed mixed cellular type of HL. Although we report a single case, it should be kept in mind that anti-TNF drugs might cause lymphoma development not only in RA, but also in AS.
引用
收藏
相关论文
共 50 条
  • [31] Etanercept reduces fatigue in subjects with ankylosing spondylitis
    Dougados, M
    Woolley, JM
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 244 - 244
  • [32] Effect of etanercept on iritis in patients with ankylosing spondylitis
    Rosenbaum, JT
    ARTHRITIS AND RHEUMATISM, 2004, 50 (11): : 3736 - 3737
  • [33] Efficacy of etanercept in ankylosing spondylitis hip lesions
    Wang, Dongxue
    Ma, Li
    Wu, Donghai
    JOINT BONE SPINE, 2011, 78 (05) : 531 - 532
  • [34] Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
    Chang, Sun Hee
    Lee, Hye Ran
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [35] COST - EFFECTIVENESS STUDY OF ETANERCEPT AS FIRST LINE TREATMENT FOR ANKYLOSING SPONDYLITIS IN COLOMBIA
    Castano Gamboa, N.
    Reyes, J.
    Rodriguez, A.
    VALUE IN HEALTH, 2018, 21 : S294 - S294
  • [36] Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
    van der Heijde, D.
    Landewe, R.
    Einstein, S.
    Ory, P.
    Vosse, D.
    Ni, L.
    Lin, S. -L.
    Tsuji, W.
    Davis, J. C., Jr.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1324 - 1331
  • [37] Decreased peripheral T cell reactivity in ankylosing spondylitis after treatment with etanercept
    Pang, L.
    Wang, L.
    Suo, T.
    Hao, H.
    Fang, X.
    Zhang, J.
    Jia, J.
    Huang, F.
    Tang, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 407 - 407
  • [38] Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: A systematic review and economic evaluation
    McLeod, C.
    Bagust, A.
    Boland, A.
    Dagenais, P.
    Dickson, R.
    Dundar, Y.
    Hill, R. A.
    Jones, A.
    Mota, R. Mujica
    Walley, T.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (28) : IX - +
  • [39] Clinical and laboratory improvement in ankylosing spondylitis after treatment with etanercept - A case report
    Cohen, JS
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2000, 6 (04) : 221 - 224
  • [40] COMBINATION TREATMENT WITH ETANERCEPT AND AN INTENSIVE SPA REHABILITATION PROGRAM IN ACTIVE ANKYLOSING SPONDYLITIS
    Colina, M.
    Ciancio, G.
    Garavini, R.
    Conti, M.
    Trotta, F.
    Govoni, M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (04) : 1125 - 1129
12345